免疫球蛋白G1(IgG1)多克隆抗體(異硫氰酸熒光素標(biāo)記)
FITC-Linked Polyclonal Antibody to Immunoglobulin G1 (IgG1)
IGHG1; Ig Gamma-1 Chain C Region; Immunoglobulin Heavy Constant Gamma 1; G1m Marker; Immunoglobulin Gm1
- 編號(hào)LAA074Mu81
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源抗體標(biāo)記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物熒光素
- 原抗體 PAA074Mu01-免疫球蛋白G1(IgG1)多克隆抗體
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IF.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 815 ¥ 1903 ¥ 2718 ¥ 6795 ¥ 27180
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)IgG1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別IgG1。
用法
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| NPA074Mu01 | 免疫球蛋白G1(IgG1)天然蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA074Mu01 | 免疫球蛋白G1(IgG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA074Mu02 | 免疫球蛋白G1(IgG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPA074Mu21 | 免疫球蛋白G1(IgG1)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| CPA074Mu22 | 免疫球蛋白G1(IgG1)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAA074Mu02 | 免疫球蛋白G1(IgG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA074Mu08 | 免疫球蛋白G1(IgG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA074Mu01 | 免疫球蛋白G1(IgG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA074Mu09 | 免疫球蛋白G1(IgG1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA074Mu81 | 免疫球蛋白G1(IgG1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| CEA074Mu | 免疫球蛋白G1(IgG1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA074Mu | 免疫球蛋白G1(IgG1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| BioMed Research International | The Effect of CXC Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling [Hindawi:Source] |
| Oncology Reports | Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer [Pubmed:25529861] |
| Cellular Immunology | IgG autoantibody subclasses altered in immuno-related hemocytopenia [Pubmed:25666506] |
| Biomed Res Int | The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling [PubMed: 26161394] |
| Gut Pathog. | Oral administration of Clostridium butyricum CGMCC0313‐1 reduces ovalbumin‐induced allergic airway inflammation in mice [pubmed:28250847] |
| Biomedicine & Pharmacotherapy | Icariin stimulates osteogenic differentiation of rat bone marrow stromal stem cells by increasing TAZ expression [pubmed:28486190] |
| Asian Pacific Society of Respirology | Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumin-induced allergic airway inflammation in mice [pubmed:28122397] |
| INTERNATIONAL JOURNAL OF MOLECULAR?SCIENCES? | Adipose Tissue-Derived Mesenchymal Stem Cell Modulates the Immune Response of Allergic Rhinitis in a Rat Model [Pubmed: 30781605] |
| Veterinary Microbiology | Optimized GAPDH-truncated immunogen of Streptococcus equi elicits an enhanced immune response and provides effective protection in a mouse model [33647714] |
| British Journal of Pharmacology | The suppression of Brd4 inhibits peripheral plasma cell differentiation and exhibits therapeutic potential for systemic lupus erythematosus [] |
